You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

~ Buy the FERROSOFERRIC OXIDE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) FERROSOFERRIC OXIDE

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing FERROSOFERRIC OXIDE excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	SYMBYAX	olanzapine and fluoxetine hydrochloride	0002-3231	FERROSOFERRIC OXIDE
Eli Lilly and Company	RETEVMO	selpercatinib	0002-3977	FERROSOFERRIC OXIDE	2038-10-10
Eli Lilly and Company	REYVOW	lasmiditan	0002-4312	FERROSOFERRIC OXIDE	2037-12-05
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing FERROSOFERRIC OXIDE excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Eli Lilly and Company	olanzapine and fluoxetine hydrochloride	0002-3231	FERROSOFERRIC OXIDE
Eli Lilly and Company	selpercatinib	0002-3977	FERROSOFERRIC OXIDE
Eli Lilly and Company	lasmiditan	0002-4312	FERROSOFERRIC OXIDE
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.